On Wednesday 12 July, the European Commission and the European Investment Bank (EIB) announced the creation of HERA Invest, a €100 million financing package to complement the InvestEU programme.
The aim is to support research and development (R&D) into the most pressing cross-border threats to health, through the ‘EU4Health’ programme.
At present, European companies are finding it difficult to access sufficient public and private funding to develop and intensify the deployment of...